annual CFO:
$96.62M+$47.99M(+98.69%)Summary
- As of today (September 14, 2025), LGND annual cash flow from operations is $96.62 million, with the most recent change of +$47.99 million (+98.69%) on December 31, 2024.
- During the last 3 years, LGND annual CFO has risen by +$17.82 million (+22.62%).
- LGND annual CFO is now -50.21% below its all-time high of $194.06 million, reached on December 31, 2018.
Performance
LGND Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$15.80M+$41.31M(+161.91%)Summary
- As of today (September 14, 2025), LGND quarterly cash flow from operations is $15.80 million, with the most recent change of +$41.31 million (+161.91%) on June 30, 2025.
- Over the past year, LGND quarterly CFO has increased by +$2.54 million (+19.16%).
- LGND quarterly CFO is now -78.55% below its all-time high of $73.64 million, reached on June 30, 2018.
Performance
LGND quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$54.95M+$2.54M(+4.85%)Summary
- As of today (September 14, 2025), LGND TTM cash flow from operations is $54.95 million, with the most recent change of +$2.54 million (+4.85%) on June 30, 2025.
- Over the past year, LGND TTM CFO has increased by +$8.24 million (+17.65%).
- LGND TTM CFO is now -72.30% below its all-time high of $198.36 million, reached on June 30, 2018.
Performance
LGND TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
LGND Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +98.7% | +19.2% | +17.6% |
| 3 y3 years | +22.6% | +33.0% | -50.7% |
| 5 y5 years | +429.4% | -35.2% | +97.9% |
LGND Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -29.9% | +98.7% | -70.5% | +161.9% | -60.1% | +64.7% |
| 5 y | 5-year | -29.9% | +429.4% | -70.5% | +161.9% | -60.1% | +97.9% |
| alltime | all time | -50.2% | +169.8% | -78.5% | +118.8% | -72.3% | +129.4% |
LGND Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $15.80M(-161.9%) | $54.95M(+4.8%) |
| Mar 2025 | - | -$25.52M(-190.0%) | $52.41M(-45.8%) |
| Dec 2024 | $96.62M(+98.7%) | $28.35M(-21.9%) | $96.62M(+28.2%) |
| Sep 2024 | - | $36.32M(+174.0%) | $75.38M(+61.4%) |
| Jun 2024 | - | $13.26M(-29.1%) | $46.71M(+40.0%) |
| Mar 2024 | - | $18.69M(+162.7%) | $33.37M(-31.4%) |
| Dec 2023 | $48.63M(-64.7%) | $7.12M(-6.9%) | $48.63M(-48.8%) |
| Sep 2023 | - | $7.65M(-9424.4%) | $94.98M(-11.9%) |
| Jun 2023 | - | -$82.00K(-100.2%) | $107.83M(-10.0%) |
| Mar 2023 | - | $33.95M(-36.5%) | $119.79M(-13.1%) |
| Dec 2022 | $137.85M(+74.9%) | $53.47M(+161.0%) | $137.85M(+23.1%) |
| Sep 2022 | - | $20.49M(+72.5%) | $112.02M(+0.4%) |
| Jun 2022 | - | $11.88M(-77.2%) | $111.56M(-7.1%) |
| Mar 2022 | - | $52.01M(+88.2%) | $120.06M(+52.4%) |
| Dec 2021 | $78.80M(+44.4%) | $27.64M(+38.0%) | $78.80M(+52.4%) |
| Sep 2021 | - | $20.02M(-1.7%) | $51.69M(+16.4%) |
| Jun 2021 | - | $20.38M(+89.5%) | $44.41M(-8.3%) |
| Mar 2021 | - | $10.75M(+1902.6%) | $48.42M(-11.3%) |
| Dec 2020 | $54.59M(-286.1%) | $537.00K(-95.8%) | $54.59M(+16.9%) |
| Sep 2020 | - | $12.74M(-47.7%) | $46.71M(+68.2%) |
| Jun 2020 | - | $24.38M(+44.1%) | $27.77M(-148.1%) |
| Mar 2020 | - | $16.92M(-330.6%) | -$57.67M(+96.6%) |
| Dec 2019 | -$29.34M(-115.1%) | -$7.34M(+18.4%) | -$29.34M(-377.4%) |
| Sep 2019 | - | -$6.20M(-89.9%) | $10.57M(-75.9%) |
| Jun 2019 | - | -$61.06M(-234.9%) | $43.85M(-75.4%) |
| Mar 2019 | - | $45.26M(+38.9%) | $178.56M(-8.0%) |
| Dec 2018 | $194.06M(+107.4%) | $32.57M(+20.3%) | $194.06M(-1.9%) |
| Sep 2018 | - | $27.08M(-63.2%) | $197.79M(-0.3%) |
| Jun 2018 | - | $73.64M(+21.2%) | $198.36M(+52.5%) |
| Mar 2018 | - | $60.76M(+67.3%) | $130.11M(+39.1%) |
| Dec 2017 | $93.57M(+48.5%) | $36.31M(+31.3%) | $93.57M(+19.6%) |
| Sep 2017 | - | $27.65M(+413.2%) | $78.25M(+13.2%) |
| Jun 2017 | - | $5.39M(-77.8%) | $69.13M(-6.7%) |
| Mar 2017 | - | $24.22M(+15.4%) | $74.11M(+17.6%) |
| Dec 2016 | $63.00M(+55.7%) | $20.99M(+13.3%) | $63.00M(+14.4%) |
| Sep 2016 | - | $18.52M(+78.6%) | $55.07M(+17.2%) |
| Jun 2016 | - | $10.37M(-20.9%) | $46.99M(+0.7%) |
| Mar 2016 | - | $13.11M(+0.4%) | $46.66M(+15.3%) |
| Dec 2015 | $40.47M(+96.8%) | $13.06M(+25.2%) | $40.47M(+7.5%) |
| Sep 2015 | - | $10.44M(+3.9%) | $37.65M(+21.7%) |
| Jun 2015 | - | $10.05M(+45.2%) | $30.95M(+24.2%) |
| Mar 2015 | - | $6.92M(-32.5%) | $24.91M(+21.1%) |
| Dec 2014 | $20.57M(-0.6%) | $10.25M(+174.3%) | $20.57M(-8.0%) |
| Sep 2014 | - | $3.73M(-6.8%) | $22.35M(+22.4%) |
| Jun 2014 | - | $4.01M(+55.5%) | $18.26M(-13.8%) |
| Mar 2014 | - | $2.58M(-78.6%) | $21.19M(+2.4%) |
| Dec 2013 | $20.69M(>+9900.0%) | $12.03M(-3452.1%) | $20.69M(+91.1%) |
| Sep 2013 | - | -$359.00K(-105.2%) | $10.83M(+5.4%) |
| Jun 2013 | - | $6.94M(+233.8%) | $10.28M(+294.1%) |
| Mar 2013 | - | $2.08M(-4.3%) | $2.61M(+1519.9%) |
| Dec 2012 | $161.00K(-113.7%) | $2.17M(-338.7%) | $161.00K(-96.8%) |
| Sep 2012 | - | -$910.00K(+24.3%) | $5.01M(+3.0%) |
| Jun 2012 | - | -$732.00K(+98.4%) | $4.86M(-298.2%) |
| Mar 2012 | - | -$369.00K(-105.3%) | -$2.45M(+109.2%) |
| Dec 2011 | -$1.17M(-95.7%) | $7.02M(-765.1%) | -$1.17M(-87.6%) |
| Sep 2011 | - | -$1.05M(-86.9%) | -$9.49M(-41.1%) |
| Jun 2011 | - | -$8.04M(-983.1%) | -$16.11M(+56.7%) |
| Mar 2011 | - | $911.00K(-170.1%) | -$10.28M(-62.0%) |
| Dec 2010 | -$27.07M(-19.9%) | -$1.30M(-83.1%) | -$27.07M(+0.0%) |
| Sep 2010 | - | -$7.67M(+246.1%) | -$27.06M(-11.9%) |
| Jun 2010 | - | -$2.22M(-86.0%) | -$30.72M(+20.2%) |
| Mar 2010 | - | -$15.88M(+1131.7%) | -$25.56M(-24.4%) |
| Dec 2009 | -$33.80M | -$1.29M(-88.6%) | -$33.80M(+28.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$11.34M(-484.4%) | -$26.32M(-7.4%) |
| Jun 2009 | - | $2.95M(-112.2%) | -$28.43M(-19.6%) |
| Mar 2009 | - | -$24.12M(-489.5%) | -$35.35M(+71.4%) |
| Dec 2008 | -$20.63M(-78.9%) | $6.19M(-146.1%) | -$20.63M(-42.1%) |
| Sep 2008 | - | -$13.45M(+238.7%) | -$35.60M(-2.2%) |
| Jun 2008 | - | -$3.97M(-57.8%) | -$36.39M(-41.1%) |
| Mar 2008 | - | -$9.40M(+7.0%) | -$61.78M(-36.8%) |
| Dec 2007 | -$97.73M(-29.4%) | -$8.79M(-38.3%) | -$97.73M(-43.5%) |
| Sep 2007 | - | -$14.23M(-51.5%) | -$173.01M(-7.4%) |
| Jun 2007 | - | -$29.36M(-35.3%) | -$186.80M(+14.0%) |
| Mar 2007 | - | -$45.35M(-46.1%) | -$163.89M(+18.3%) |
| Dec 2006 | -$138.52M(-1756.0%) | -$84.07M(+200.0%) | -$138.52M(+226.9%) |
| Sep 2006 | - | -$28.02M(+334.6%) | -$42.38M(+460.3%) |
| Jun 2006 | - | -$6.45M(-67.7%) | -$7.56M(-16.2%) |
| Mar 2006 | - | -$19.98M(-265.5%) | -$9.02M(-207.9%) |
| Dec 2005 | $8.37M(+45.4%) | $12.07M(+77.7%) | $8.37M(-67.2%) |
| Sep 2005 | - | $6.79M(-186.0%) | $25.46M(+118.9%) |
| Jun 2005 | - | -$7.91M(+204.4%) | $11.63M(+47.4%) |
| Mar 2005 | - | -$2.60M(-108.9%) | $7.89M(+37.1%) |
| Dec 2004 | $5.75M(+2000.0%) | $29.17M(-514.4%) | $5.75M(-140.4%) |
| Sep 2004 | - | -$7.04M(-39.6%) | -$14.24M(+45.1%) |
| Jun 2004 | - | -$11.65M(+146.1%) | -$9.81M(-285.6%) |
| Mar 2004 | - | -$4.73M(-151.6%) | $5.29M(+1829.9%) |
| Dec 2003 | $274.00K(-101.1%) | $9.18M(-451.4%) | $274.00K(-101.5%) |
| Sep 2003 | - | -$2.61M(-175.5%) | -$18.46M(-4.7%) |
| Jun 2003 | - | $3.46M(-135.5%) | -$19.38M(-44.2%) |
| Mar 2003 | - | -$9.75M(+1.9%) | -$34.72M(+38.3%) |
| Dec 2002 | -$25.11M(+26.2%) | -$9.56M(+171.2%) | -$25.11M(+32.0%) |
| Sep 2002 | - | -$3.53M(-70.3%) | -$19.02M(-15.3%) |
| Jun 2002 | - | -$11.88M(+8327.7%) | -$22.45M(+225.1%) |
| Mar 2002 | - | -$141.00K(-95.9%) | -$6.91M(-65.3%) |
| Dec 2001 | -$19.91M(-58.0%) | -$3.47M(-50.1%) | -$19.91M(-22.2%) |
| Sep 2001 | - | -$6.96M(-289.9%) | -$25.59M(-25.2%) |
| Jun 2001 | - | $3.66M(-127.9%) | -$34.21M(-26.6%) |
| Mar 2001 | - | -$13.14M(+43.6%) | -$46.63M(-1.5%) |
| Dec 2000 | -$47.35M(-21.8%) | -$9.15M(-41.3%) | -$47.35M(-2.3%) |
| Sep 2000 | - | -$15.58M(+77.9%) | -$48.47M(+2.7%) |
| Jun 2000 | - | -$8.76M(-36.8%) | -$47.18M(-10.0%) |
| Mar 2000 | - | -$13.86M(+35.0%) | -$52.41M(-13.4%) |
| Dec 1999 | -$60.54M(-9.2%) | -$10.27M(-28.2%) | -$60.54M(-9.5%) |
| Sep 1999 | - | -$14.29M(+2.2%) | -$66.87M(-5.6%) |
| Jun 1999 | - | -$13.99M(-36.4%) | -$70.86M(+3.4%) |
| Mar 1999 | - | -$21.99M(+32.6%) | -$68.56M(+2.9%) |
| Dec 1998 | -$66.65M(+398.9%) | -$16.59M(-9.3%) | -$66.65M(+79.9%) |
| Sep 1998 | - | -$18.29M(+56.5%) | -$37.06M(+27.9%) |
| Jun 1998 | - | -$11.69M(-41.8%) | -$28.97M(+14.6%) |
| Mar 1998 | - | -$20.09M(-254.5%) | -$25.29M(+88.7%) |
| Dec 1997 | -$13.36M(-59.9%) | $13.00M(-227.5%) | -$13.40M(-59.0%) |
| Sep 1997 | - | -$10.20M(+27.5%) | -$32.70M(+0.6%) |
| Jun 1997 | - | -$8.00M(-2.4%) | -$32.50M(-2.4%) |
| Mar 1997 | - | -$8.20M(+30.2%) | -$33.30M(0.0%) |
| Dec 1996 | -$33.30M(-12.1%) | -$6.30M(-37.0%) | -$33.30M(+23.3%) |
| Sep 1996 | - | -$10.00M(+13.6%) | -$27.00M(+58.8%) |
| Jun 1996 | - | -$8.80M(+7.3%) | -$17.00M(+107.3%) |
| Mar 1996 | - | -$8.20M(+182.8%) | -$8.20M(-43.1%) |
| Dec 1995 | -$37.87M(+164.7%) | - | - |
| Mar 1995 | - | -$2.90M(-31.0%) | -$14.40M(+0.7%) |
| Dec 1994 | -$14.31M(+34.9%) | -$4.20M(+40.0%) | -$14.30M(+41.6%) |
| Sep 1994 | - | -$3.00M(-30.2%) | -$10.10M(+42.3%) |
| Jun 1994 | - | -$4.30M(+53.6%) | -$7.10M(+153.6%) |
| Mar 1994 | - | -$2.80M | -$2.80M |
| Dec 1993 | -$10.61M(+1.1%) | - | - |
| Dec 1992 | -$10.49M | - | - |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual cash flow from operations?
- What is the all time high annual CFO for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual CFO year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly cash flow from operations?
- What is the all time high quarterly CFO for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly CFO year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM cash flow from operations?
- What is the all time high TTM CFO for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM CFO year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual cash flow from operations?
The current annual CFO of LGND is $96.62M
What is the all time high annual CFO for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual cash flow from operations is $194.06M
What is Ligand Pharmaceuticals Incorporated annual CFO year-on-year change?
Over the past year, LGND annual cash flow from operations has changed by +$47.99M (+98.69%)
What is Ligand Pharmaceuticals Incorporated quarterly cash flow from operations?
The current quarterly CFO of LGND is $15.80M
What is the all time high quarterly CFO for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly cash flow from operations is $73.64M
What is Ligand Pharmaceuticals Incorporated quarterly CFO year-on-year change?
Over the past year, LGND quarterly cash flow from operations has changed by +$2.54M (+19.16%)
What is Ligand Pharmaceuticals Incorporated TTM cash flow from operations?
The current TTM CFO of LGND is $54.95M
What is the all time high TTM CFO for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM cash flow from operations is $198.36M
What is Ligand Pharmaceuticals Incorporated TTM CFO year-on-year change?
Over the past year, LGND TTM cash flow from operations has changed by +$8.24M (+17.65%)